Published on 25 May by Granma
It has been five months since Presidents Raúl Castro and Barack Obama announced on December 17 their intention to open a new chapter in relations between the United States and Cuba.
After an historic meeting between both leaders at the 7th Summit of the Americas, on May 21, the third round of conversations began in Washington, with the goal of advancing toward the reestablishment of diplomatic relations and the opening of embassies in both countries,.
Although talks between the U.S. and Cuba are already, in themselves, a milestone for two neighboring countries which have lacked formal ties for more than half a century, they only mark the beginning of a much longer and complicated process.
Inaccuracies and distorted information have accompanied this process from the beginning.Granma shares with its readers seven key points which clarify the dimension of what is happening between Havana and Washington and the coming stage.
Published on 25 May by Granma
One month has past since the devastating April 25 earthquake in Nepal, and two weeks since the powerful May 12 aftershock, the same night Cuba’s Henry Reeve Medical Brigade arrived in the country. Forty-nine Cuban medical professionals are taking on the population’s needs, defying the damage, fear and grief around them.
Cities lie in ruin and the number of victims has surpassed 8,600. Anxiety remains fixed on faces, since the country continues to experience aftershocks.
On the night of May 12, the same night a severe aftershock hit the nation, 49 members of the Henry Reeve International Contingent Specialized in Disasters and Large Epidemics Brigade No.41 arrived in Katmandu.
“The landscape was disheartening, Dantesque, I would say. The country didn’t need nature to punish it this way. Those who managed to save their lives in the most affected areas have lost practically everything, including their most cherished loved ones,” Dr. Luis Orlando Oliveros Serrano, head of the Brigade, told Granma.
Published on 26 May 2015 by TeleSUR English
Cuban officials with the Center for the Study of Population and Development, known as CEPDE, revealed Monday that life expectancy in Cuba, already one of the highest in the world, now reaches 78.45 years. Juan Carlos Alfonso Fraga, director of CEPDE, said the figure represents an increase of nearly half a year over the previous study of life expectancy on the island. He added that the bump was seen throughout all the provinces of Cuba and not just confined to urban areas, where medical attention tends to be of better quality.
Life expectancy for women was slightly higher at 80.45 years, with the life span for men at 76.50 years. Cuba is in the top 25 countries in the world for life expectancy, which is considered an important indicator of human development and quality of healthcare. Despite its status as a low-income country, Cuba's medical system is recognized as one of the best in the world.
Published on 14 may 2015 by Granma
Two days of fruitful debate in the 5th CIMAvax-EGF International Workshop on the first registered therapeutic vaccine against lung cancer, confirmed that after two decades of clinical experience in the use of this vaccine, the treatment has been proven safe and effective given the positive reaction of patients, the increase in survival rates and improved quality of life.
An excellent prognosis in a context where lung cancer, according to the Annual Health Statistics report 2014, is among the top causes of death for both men and women in the country, and is one of the illnesses showing the greatest increase in both genders.
The Workshop, organized by CIMAB S.A - biopharmaceutical entity dedicated to the development and commercialization of cancer medicines, affiliated with the Molecular Immunology Center (CIM) - was the ideal place to present the final results of the study confirming the effectiveness of CIMAvax-EGF in treating advanced pulmonary cancer; the use of the vaccine in treating lung cancer at a primary healthcare level; its global safety accreditation; biomarkers to predict patients’ response to the vaccine; post-registration experiences in other countries; CIMAvax-EGF in the context of therapies directed toward patients with lung cancer; and its use in treating prostate cancer.
According to information presented during the event, more than 3,000 patients, the majority Cubans, have benefited from the vaccine. Dr. Giselle Suárez, expert at CIM’s commercial office, reported to the press that since 2015, the vaccine has been included in the country’s basic catalogue of essential medicines, and is available across all levels of the national health system.